Multiple circulating forms of neprilysin detected with novel epitope-directed monoclonal antibodies

Neprilysin (NEP) is an emerging biomarker for various diseases including heart failure (HF). However, major inter-assay inconsistency in the reported concentrations of circulating NEP and uncertainty with respect to its correlations with type and severity of disease are in part attributed to poorly...

Ausführliche Beschreibung